Published in Cancer Weekly, April 15th, 2008
The trial was designed to show a statistically significant improvement in overall survival for UMM patients who were treated with a combination of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.